ANI PHARMACEUTICALS, INC Costs and Expenses
ANI PHARMACEUTICALS, INC (ANIP) reported Costs and Expenses of $225.58 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC costs and expenses for the quarter ending 2026-06-30 was $225.58M, a 14.23% increase year-over-year.
- ANI PHARMACEUTICALS, INC costs and expenses for the quarter ending 2026-03-31 was $198.57M, a 16.17% increase year-over-year.
- ANI PHARMACEUTICALS, INC costs and expenses for the quarter ending 2025-12-31 was $212.29M, a 8.90% increase year-over-year.
- ANI PHARMACEUTICALS, INC costs and expenses for the quarter ending 2025-09-30 was $191.57M, a 13.46% increase year-over-year.
- ANI PHARMACEUTICALS, INC costs and expenses for fiscal 2025 was $772.27M, a 25.82% increase from fiscal 2024.
- ANI PHARMACEUTICALS, INC costs and expenses for fiscal 2024 was $613.79M, a 39.55% increase from fiscal 2023.
- ANI PHARMACEUTICALS, INC costs and expenses for fiscal 2023 was $439.85M, a 25.07% increase from fiscal 2022.
- ANI PHARMACEUTICALS, INC costs and expenses for fiscal 2022 was $351.67M, a 37.41% increase from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $225.58M 10-Q · filed 2026-08-07 | $424.16M 10-Q · filed 2026-08-07 | $636.45M derived: sum of 3 quarters · filed 2026-08-07 | $828.02M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $198.57M 10-Q · filed 2026-05-08 | $410.87M derived: sum of 2 quarters · filed 2026-05-08 | $602.44M derived: sum of 3 quarters · filed 2026-05-08 | $799.92M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $212.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $403.87M derived: sum of 2 quarters · filed 2026-02-27 | $601.35M derived: sum of 3 quarters · filed 2026-08-07 | $772.27M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $191.57M 10-Q · filed 2025-11-07 | $389.05M derived: sum of 2 quarters · filed 2026-08-07 | $559.98M 10-Q · filed 2025-11-07 | $754.93M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $197.48M 10-Q · filed 2026-08-07 | $368.41M 10-Q · filed 2026-08-07 | $563.36M derived: sum of 3 quarters · filed 2026-08-07 | $732.21M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $170.93M 10-Q · filed 2026-05-08 | $365.88M derived: sum of 2 quarters · filed 2026-05-08 | $534.73M derived: sum of 3 quarters · filed 2026-05-08 | $667.60M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $194.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $363.80M derived: sum of 2 quarters · filed 2026-02-27 | $496.67M derived: sum of 3 quarters · filed 2026-02-27 | $613.79M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $168.85M 10-Q · filed 2025-11-07 | $301.72M derived: sum of 2 quarters · filed 2025-11-07 | $418.84M 10-Q · filed 2025-11-07 | $543.77M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $132.87M 10-Q · filed 2025-08-08 | $249.99M 10-Q · filed 2025-08-08 | $374.92M derived: sum of 3 quarters · filed 2026-02-27 | $488.80M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $117.12M 10-Q · filed 2025-05-09 | $242.05M derived: sum of 2 quarters · filed 2026-02-27 | $355.93M derived: sum of 3 quarters · filed 2026-02-27 | $460.07M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $124.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $238.81M derived: sum of 2 quarters · filed 2026-02-27 | $342.95M derived: sum of 3 quarters · filed 2026-02-27 | $439.85M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $113.88M 10-Q · filed 2024-11-08 | $218.03M derived: sum of 2 quarters · filed 2024-11-08 | $314.92M 10-Q · filed 2024-11-08 | $407.33M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $104.14M 10-Q · filed 2024-08-06 | $201.04M 10-Q · filed 2024-08-06 | $293.45M derived: sum of 3 quarters · filed 2025-02-28 | $382.26M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $96.89M 10-Q · filed 2024-05-10 | $189.30M derived: sum of 2 quarters · filed 2025-02-28 | $278.12M derived: sum of 3 quarters · filed 2025-02-28 | $364.89M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $92.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $181.23M derived: sum of 2 quarters · filed 2025-02-28 | $268.00M derived: sum of 3 quarters · filed 2025-02-28 | $351.67M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $88.82M 10-Q · filed 2023-11-08 | $175.58M derived: sum of 2 quarters · filed 2023-11-08 | $259.26M 10-Q · filed 2023-11-08 | $343.91M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $86.77M 10-Q · filed 2023-08-09 | $170.44M 10-Q · filed 2023-08-09 | $255.09M derived: sum of 3 quarters · filed 2024-02-29 | $310.71M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $83.67M 10-Q · filed 2023-05-08 | $168.32M derived: sum of 2 quarters · filed 2024-02-29 | $223.95M derived: sum of 3 quarters · filed 2024-02-29 | $288.13M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $84.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $140.28M derived: sum of 2 quarters · filed 2024-02-29 | $204.45M derived: sum of 3 quarters · filed 2024-02-29 | $255.93M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $55.62M 10-Q · filed 2022-11-09 | $119.80M derived: sum of 2 quarters · filed 2022-11-09 | $171.28M 10-Q · filed 2022-11-09 | $228.20M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $64.18M 10-Q · filed 2022-08-08 | $115.65M 10-Q · filed 2022-08-08 | $172.57M derived: sum of 3 quarters · filed 2022-08-08 | $222.75M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $51.48M 10-Q · filed 2022-05-10 | $108.40M derived: sum of 2 quarters · filed 2022-05-10 | $158.57M derived: sum of 3 quarters · filed 2022-05-10 | $218.35M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $56.92M 10-K · filed 2021-03-11 | $107.10M derived: sum of 2 quarters · filed 2021-11-01 | $166.88M derived: sum of 3 quarters · filed 2021-11-01 | $224.49M 10-K · filed 2023-03-09 | ||||
| 2020-09-30 | $50.18M 10-Q · filed 2021-11-01 | $109.95M derived: sum of 2 quarters · filed 2021-11-01 | $167.57M 10-Q · filed 2021-11-01 | $220.21M derived: sum of 4 quarters · filed 2021-11-01 | ||||
| 2020-06-30 | $59.78M 10-Q · filed 2021-08-06 | $117.39M 10-Q · filed 2021-08-06 | $170.03M derived: sum of 3 quarters · filed 2021-08-06 | $214.04M derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $57.62M 10-Q · filed 2021-05-07 | $110.25M derived: sum of 2 quarters · filed 2021-05-07 | $154.26M derived: sum of 3 quarters · filed 2021-05-07 | $199.33M derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2019-12-31 | $52.64M 10-K · filed 2021-03-11 | $96.65M derived: sum of 2 quarters · filed 2021-03-11 | $141.71M derived: sum of 3 quarters · filed 2021-03-11 | $190.20M 10-K · filed 2022-03-15 | ||||
| 2019-09-30 | $44.01M 10-K · filed 2021-03-11 | $89.07M derived: sum of 2 quarters · filed 2021-03-11 | $137.56M 10-Q · filed 2020-11-05 | $183.24M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-06-30 | $45.06M 10-K · filed 2021-03-11 | $93.55M 10-Q · filed 2020-08-06 | $139.23M derived: sum of 3 quarters · filed 2021-03-11 | $179.82M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-03-31 | $48.48M 10-K · filed 2021-03-11 | $94.16M derived: sum of 2 quarters · filed 2021-03-11 | $134.75M derived: sum of 3 quarters · filed 2021-03-11 | $174.76M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2018-12-31 | $45.68M 10-K · filed 2020-02-27 | $86.27M derived: sum of 2 quarters · filed 2020-02-27 | $126.27M derived: sum of 3 quarters · filed 2020-02-27 | $166.22M 10-K · filed 2021-03-11 | ||||
| 2018-09-30 | $40.59M 10-K · filed 2020-02-27 | $80.59M derived: sum of 2 quarters · filed 2020-02-27 | $120.54M 10-Q · filed 2019-11-06 | $160.45M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $40.01M 10-K · filed 2020-02-27 | $79.95M 10-Q · filed 2019-08-07 | $119.86M derived: sum of 3 quarters · filed 2020-02-27 | $158.69M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $39.95M 10-K · filed 2020-02-27 | $79.85M derived: sum of 2 quarters · filed 2020-02-27 | $118.69M derived: sum of 3 quarters · filed 2020-02-27 | $156.46M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $39.91M 10-K · filed 2019-02-27 | $78.74M derived: sum of 2 quarters · filed 2019-02-27 | $116.51M derived: sum of 3 quarters · filed 2019-02-27 | $148.51M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $38.83M 10-K · filed 2019-02-27 | $76.60M derived: sum of 2 quarters · filed 2019-02-27 | $108.61M 10-Q · filed 2018-11-06 | $145.51M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $37.77M 10-K · filed 2019-02-27 | $69.77M 10-Q · filed 2018-08-07 | $106.68M derived: sum of 3 quarters · filed 2019-02-27 | $137.28M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $32.00M 10-K · filed 2019-02-27 | $68.91M derived: sum of 2 quarters · filed 2019-02-27 | $99.51M derived: sum of 3 quarters · filed 2019-02-27 | $125.66M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $36.91M 10-K · filed 2018-02-27 | $67.51M derived: sum of 2 quarters · filed 2018-02-27 | $93.65M derived: sum of 3 quarters · filed 2018-02-27 | $108.54M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $30.60M 10-K · filed 2018-02-27 | $56.75M derived: sum of 2 quarters · filed 2018-02-27 | $71.64M 10-Q · filed 2017-11-02 | $83.40M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $26.14M 10-K · filed 2018-02-27 | $41.03M 10-Q · filed 2017-08-03 | $52.80M derived: sum of 3 quarters · filed 2018-02-27 | $64.32M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $14.89M 10-K · filed 2018-02-27 | $26.66M derived: sum of 2 quarters · filed 2018-02-27 | $38.18M derived: sum of 3 quarters · filed 2018-02-27 | $49.28M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $11.77M 10-K · filed 2017-03-02 | $23.29M derived: sum of 2 quarters · filed 2017-03-02 | $34.39M derived: sum of 3 quarters · filed 2017-03-02 | $43.62M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $11.52M 10-K · filed 2017-03-02 | $22.62M derived: sum of 2 quarters · filed 2017-03-02 | $31.86M 10-Q · filed 2016-11-03 | $42.12M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-06-30 | $11.10M 10-K · filed 2017-03-02 | $20.33M 10-Q · filed 2016-08-04 | $30.60M derived: sum of 3 quarters · filed 2017-03-02 | $39.79M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-03-31 | $9.23M 10-K · filed 2017-03-02 | $19.50M derived: sum of 2 quarters · filed 2017-03-02 | $28.68M derived: sum of 3 quarters · filed 2017-03-02 | $37.79M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2014-12-31 | $10.27M 10-K · filed 2016-02-23 | $19.45M derived: sum of 2 quarters · filed 2016-02-23 | $28.56M derived: sum of 3 quarters · filed 2016-02-23 | $35.96M 10-K · filed 2017-03-02 | ||||
| 2014-09-30 | $9.19M 10-K · filed 2016-02-23 | $18.30M derived: sum of 2 quarters · filed 2016-02-23 | $25.70M 10-Q · filed 2015-11-03 | $32.77M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $9.11M 10-K · filed 2016-02-23 | $16.51M 10-Q · filed 2015-08-04 | $23.58M derived: sum of 3 quarters · filed 2016-02-23 | $30.61M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $7.40M 10-K · filed 2016-02-23 | $14.48M derived: sum of 2 quarters · filed 2016-02-23 | $21.50M derived: sum of 3 quarters · filed 2016-02-23 | $31.43M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $14.10M derived: sum of 2 quarters · filed 2016-02-23 | $24.02M derived: sum of 3 quarters · filed 2016-02-23 | $29.18M 10-K · filed 2016-02-23 | ||||
| 2013-09-30 | $7.03M 10-Q · filed 2014-11-10 | $7.03M 10-Q · filed 2013-11-07 | $16.95M derived: sum of 2 quarters · filed 2014-11-10 | $22.11M 10-Q · filed 2014-11-10 | $22.11M 10-Q · filed 2013-11-07 | $28.45M derived: sum of 4 quarters · filed 2014-11-10 | ||
| 2013-06-30 | $9.93M 10-Q · filed 2014-08-07 | $9.93M 10-Q · filed 2013-08-09 | $15.09M 10-Q · filed 2014-08-07 | $15.09M 10-Q · filed 2013-08-09 | $21.42M derived: sum of 3 quarters · filed 2014-08-07 | $26.67M derived: sum of 4 quarters · filed 2014-08-07 | ||
| 2013-03-31 | $5.16M 10-Q · filed 2014-05-12 | $3.09M 10-Q · filed 2013-05-10 | $11.50M derived: sum of 2 quarters · filed 2014-05-12 | $16.74M derived: sum of 3 quarters · filed 2014-05-12 | $21.34M derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2012-12-31 | $6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $11.58M derived: sum of 2 quarters · filed 2014-02-28 | $16.18M derived: sum of 3 quarters · filed 2014-02-28 | $20.41M 10-K · filed 2014-02-28 | $25.47M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $5.24M 10-Q · filed 2013-11-07 | $5.45M 10-Q · filed 2012-11-08 | $9.84M derived: sum of 2 quarters · filed 2013-11-07 | $14.08M 10-Q · filed 2013-11-07 | $19.87M 10-Q · filed 2012-11-08 | $25.39M derived: sum of 4 quarters · filed 2013-11-07 | ||
| 2012-06-30 | $4.60M 10-Q · filed 2013-08-09 | $7.38M 10-Q · filed 2012-08-01 | $8.83M 10-Q · filed 2013-08-09 | $14.42M 10-Q · filed 2012-08-01 | $20.15M derived: sum of 3 quarters · filed 2013-08-09 | $33.36M derived: sum of 4 quarters · filed 2013-08-09 | ||
| 2012-03-31 | $7.05M 10-Q · filed 2013-05-10 | $15.55M derived: sum of 2 quarters · filed 2013-05-10 | $28.76M derived: sum of 3 quarters · filed 2013-05-10 | $41.91M derived: sum of 4 quarters · filed 2013-05-10 | ||||
| 2011-12-31 | $8.51M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $21.72M derived: sum of 2 quarters · filed 2013-02-28 | $34.86M derived: sum of 3 quarters · filed 2013-02-28 | $51.36M 10-K · filed 2013-02-28 | ||||
| 2011-09-30 | $13.21M 10-Q · filed 2012-11-08 | $26.36M derived: sum of 2 quarters · filed 2012-11-08 | $42.86M 10-Q · filed 2012-11-08 | $56.17M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $13.15M 10-Q · filed 2012-08-01 | $29.65M 10-Q · filed 2012-08-01 | $42.96M derived: sum of 3 quarters · filed 2013-02-28 | $54.25M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $16.50M 10-Q · filed 2012-05-08 | $29.81M derived: sum of 2 quarters · filed 2013-02-28 | $41.10M derived: sum of 3 quarters · filed 2013-02-28 | $51.34M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $13.31M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $24.60M derived: sum of 2 quarters · filed 2013-02-28 | $34.84M derived: sum of 3 quarters · filed 2013-02-28 | $46.08M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $11.29M 10-Q · filed 2011-11-09 | $21.53M derived: sum of 2 quarters · filed 2011-11-09 | $32.77M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $10.24M 10-Q · filed 2011-08-05 | $21.48M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $48.68M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |